Learnings from cross-border biosimilar pricing policies in Europe

Expert Rev Pharmacoecon Outcomes Res. 2024 Mar 26:1-4. doi: 10.1080/14737167.2024.2334343. Online ahead of print.

Authors

Steven Simoens¹, Teresa Barcina Lacosta¹, András Inotai^{2

3}

Affiliations

¹ Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.
² Centre for Health Technology Assessment, Semmelweis University, Budapest, Hungary.
³ Syreon Research Institute, Budapest, Hungary.

PMID: 38530083
DOI: 10.1080/14737167.2024.2334343

No abstract available

Keywords: Biosimilar; europe; policy; price; procurement; sustainability.

Publication types

Editorial